IN8bio, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 30.01 million compared to USD 28.52 million a year ago. Basic loss per share from continuing operations was USD 1 compared to USD 1.36 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -10.08% | +2.86% | -21.74% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.74% | 52.51M | |
+15.26% | 118B | |
+13.63% | 106B | |
-2.63% | 24.28B | |
+1.25% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.45% | 15.56B | |
+6.34% | 13.63B | |
+29.32% | 12.27B |
- Stock Market
- Equities
- INAB Stock
- News IN8bio, Inc.
- IN8bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023